Develops cancer genomic testing services for physicians and pharmaceutical companies.
Jun 2026Revenue $69.7M/yrExpenses $184M/yr
No trendCash runway ≈ 2.1 years from Jun 2026
Figures by year
When will Personalis be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $69.7M and expenses $184M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $69.6M | $158M | −$88.1M |
| Dec 2024 | $84.6M | $153M | −$68.3M |
| Dec 2023 | $73.5M | $183M | −$110M |
| Dec 2022 | $65.0M | $181M | −$116M |
| Dec 2021 | $85.5M | $151M | −$65.4M |
| Dec 2020 | $78.6M | $121M | −$42.1M |
| Dec 2019 | $65.2M | $87.6M | −$22.4M |
| Dec 2018 | $37.8M | $51.5M | −$13.8M |
| Dec 2017 | $9.39M | $31.6M | −$22.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.